Fort Point Capital Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$220K Buy
752
+84
+13% +$27.6K 0.03% 218
2025
Q4
$255K Hold
668
0.03% 209
2025
Q3
$216K Buy
668
+44
+7% +$13.7K 0.03% 205
2025
Q2
$243K Sell
624
-116
-16% -$46.7K 0.02% 298
2025
Q1
$322K Buy
740
+31
+4% +$12.4K 0.04% 261
2024
Q4
$262K Sell
709
-50
-7% -$20.9K 0.03% 274
2024
Q3
$395K Sell
759
-13
-2% -$6.95K 0.05% 204
2024
Q2
$418K Sell
772
-11
-1% -$5.81K 0.05% 214
2024
Q1
$406K Hold
783
0.05% 215
2023
Q4
$369K Sell
783
-1
-0.1% -$462 0.05% 212
2023
Q3
$341K Buy
784
+27
+4% +$12.2K 0.05% 189
2023
Q2
$336K Buy
757
+18
+2% +$8.3K 0.05% 205
2023
Q1
$340K Buy
739
+43
+6% +$20.5K 0.05% 203
2022
Q4
$357K Buy
696
+5
+0.7% +$2.54K 0.06% 186
2022
Q3
$314K Hold
691
0.05% 197
2022
Q2
$333K Hold
691
0.05% 207
2022
Q1
$339K Sell
691
-5
-0.7% -$2.29K 0.05% 218
2021
Q4
$323K Sell
696
-42
-6% -$17.7K 0.04% 219
2021
Q3
$275K Buy
738
+30
+4% +$11.4K 0.04% 205
2021
Q2
$270K Hold
708
0.05% 142
2021
Q1
$254K Hold
708
0.05% 135
2020
Q4
$227K Buy
+708
New +$217K 0.05% 134
2020
Q1
Sell
-728
Closed -$220K 117
2019
Q4
$220K Buy
+728
New +$200K 0.08% 118
2019
Q3
Sell
-728
Closed -$205K 123
2019
Q2
$205K Hold
728
0.08% 97
2019
Q1
$209K Buy
+728
New +$211K 0.09% 102
2018
Q4
Sell
-732
Closed -$201K 156
2018
Q3
$201K Buy
+732
New +$190K 0.06% 149

Other funds holding ELV

Fort Point Capital Partners's ELV Position: Q1 2026 in Review

Fort Point Capital Partners increased its Elevance Health (ELV) stake by 13% in Q1 2026, buying an estimated $27.6K and bringing the position to 752 shares worth $220K. The position accounts for 0.03% of the portfolio, ranked #218.

Fort Point Capital Partners first reported a position in ELV in Q3 2018 and has held it in 26 quarters since. The position peaked at $418K in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Fort Point Capital Partners held 752 shares of Elevance Health worth $220K as of Q1 2026.
  • Fort Point Capital Partners bought 84 Elevance Health shares in Q1 2026, an estimated $27.6K.
  • Elevance Health made up 0.03% of Fort Point Capital Partners's portfolio in Q1 2026, its #218 holding.
  • Fort Point Capital Partners first reported a position in Elevance Health in Q3 2018 and has held it in 26 quarters since.
  • Fort Point Capital Partners's Elevance Health position peaked at $418K in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Fort Point Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.